OHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Omega Healthcare Investors Inc (OHI) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits strong fundamentals, positive financial growth, and favorable hedge fund activity, making it a solid choice for long-term growth.
The stock is in a bullish trend with MACD histogram at 0.381 (positively expanding), RSI_6 at 77.983 (neutral zone), and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The pre-market price is $47, slightly below the R1 resistance level of $47.16, indicating potential upward movement.
Hedge funds are significantly increasing their positions, with a 251.64% rise in buying activity last quarter.
Analysts have raised price targets, with some projecting up to $
Strong financial performance in Q4 2025, with revenue up 14.28% YoY, net income up 45.43% YoY, and EPS up 29.27% YoY.
Downgrades from Wells Fargo and BMO Capital, citing valuation concerns and limited upside.
Slight gross margin decline (-0.30% YoY).
Genesis, a tenant contributing 4.6% of annualized rent, filed for Chapter 11 in 2025, creating potential risks.
In Q4 2025, Omega Healthcare reported strong growth: Revenue increased to $319.2M (up 14.28% YoY), Net Income rose to $164.8M (up 45.43% YoY), and EPS improved to $0.53 (up 29.27% YoY). However, Gross Margin slightly declined to 98.47% (-0.30% YoY).
Analysts are mixed but lean positive. Cantor Fitzgerald, UBS, and Goldman Sachs have Buy/Overweight ratings with price targets up to $54, citing strong growth and accretive capital deployment. However, Wells Fargo and BMO Capital downgraded the stock, citing valuation concerns and limited upside.
